EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clonal hematopoiesis associates with prevalent and incident cardiometabolic disease in a cardiac catheterization cohort

Jessica A Regan iD, Lydia Coulter Kwee, Navid A Nafissi, Alexander G Bick, William E Kraus iD, Pradeep Natarajan, Siddhartha Jaiswal, Svati H Shah

PLOS One · 2026

DOI: 10.1371/journal.pone.0339491 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Jessica A Regan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Duke University, Durham, North Carolina, United States of America. Hauptthemen laut MEDLINE: Clonal Hematopoiesis, Cardiac Catheterization, Cardiovascular Diseases, Heart Failure. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute, Edna and Fred L. Mandel, Jr. Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clonal hematopoiesis of indeterminate potential (CHIP) is the age-related presence of expanded somatic clones secondary to leukemogenic driver mutations and is associated with cardiovascular (CV) disease and mortality. We sought to evaluate relationships between CHIP with cardiometabolic diseases and incident outcomes in high-risk individuals.

Methods

CHIP genotyping was performed in 8469 individuals referred for cardiac catheterization at Duke University (CATHGEN study) to identify variants present at a variant allele fraction (VAF) ≥2%. Associations were tested among any CHIP variant, large CHIP clones (VAF > 10%) and individual CHIP genes with prevalent cardiometabolic traits. Cox proportional hazard models tested CHIP associations with time-to-overall mortality and Fine-Gray analyses tested CHIP associations with incident cardiovascular outcomes.

Results

We identified 463 CHIP variants in 427 individuals (5.0%) of which 268 (3.2%) harbored large CHIP clones. CHIP and large CHIP were associated with lower odds of obesity (OR 0.79 [95% CI 0.65–0.98], p = 0.03; OR 0.76 [95% CI 0.57–0.99], p = 0.04, respectively). CHIP was associated with prevalent heart failure (HF, OR 1.25 [95% CI 1.01–1.55], p = 0.04; especially for non- DNMT3A CHIP (OR 1.38 [95% CI 1.04–1.82], p = 0.02). CHIP was also associated with incident events: Non- DNMT3A CHIP was associated with increased risk of time-to-HF hospitalization (HR 1.29 [95% CI 1.02–1.63], p = 0.03).

Conclusions

In high-risk individuals referred for cardiac catheterization, large CHIP and non- DNTM3A CHIP were associated with obesity, prevalent HF, incident CV events. These findings strengthen the importance of CHIP as a biomarker for CV disease and highlight the contributing risk of large CHIP clones and non- DNMT3A CHIP variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clonal HematopoiesisCardiac CatheterizationCardiovascular DiseasesHeart FailureHumansFemaleMaleMiddle AgedAgedPrevalenceDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3ACohort StudiesIncidence

Substanzen

DNA (Cytosine-5-)-MethyltransferasesDNMT3A protein, humanDNA Methyltransferase 3A

Autor:innen und Institutionen

  • Division of Cardiology, Department of Medicine, Duke University, Durham, North Carolina, United States of America.
  • Duke Molecular Physiology Institute, Durham, North Carolina, United States of America.
  • Division of Genetic Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
  • Center for Genomic Medicine and Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
  • Program in Medical & Population Genetics, Broad Institute of Harvard & MIT, Cambridge, Massachusetts, United States of America.
  • Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America.

ORCID-Profile: Jessica A Regan, William E Kraus

Förderung

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute
  • Edna and Fred L. Mandel, Jr. Foundation

Zitieren

APA

Regan, J. A., Kwee, L. C., Nafissi, N. A., Bick, A. G., Kraus, W. E., Natarajan, P., Jaiswal, S., & Shah, S. H. (2026). Clonal hematopoiesis associates with prevalent and incident cardiometabolic disease in a cardiac catheterization cohort. PLOS One. https://doi.org/10.1371/journal.pone.0339491

Vancouver

Regan JA, Kwee LC, Nafissi NA, Bick AG, Kraus WE, Natarajan P, et al. Clonal hematopoiesis associates with prevalent and incident cardiometabolic disease in a cardiac catheterization cohort. PLOS One. 2026. doi:10.1371/journal.pone.0339491

BibTeX
@article{Regan2026,
  author = {Regan, Jessica A and Kwee, Lydia Coulter and Nafissi, Navid A and Bick, Alexander G and Kraus, William E and Natarajan, Pradeep and Jaiswal, Siddhartha and Shah, Svati H},
  title = {Clonal hematopoiesis associates with prevalent and incident cardiometabolic disease in a cardiac catheterization cohort},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0339491}
}
Kostenlos starten →